- PLX8394
-
- $1.00 / 1KG
-
2019-12-27
- CAS:1393466-87-9
- Min. Order: 1KG
- Purity: 97%-99.9%
- Supply Ability: 100kg
|
| | PLX8394 Basic information |
| Product Name: | PLX8394 | | Synonyms: | PLX8394;PLX8394;PLX-8394;PLX 8394;1-Pyrrolidinesulfonamide, N-[3-[[5-(2-cyclopropyl-5-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-3-fluoro-, (3R)-;(R)-N-(3-(5-(2-Cyclopropylpyrimidin-5-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)-3-fluoropyrrolidine-1-sulfonamide;(3R)-N-[3-[[5-(2-Cyclopropyl-5-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-3-fluoro-1-pyrrolidinesulfonamide;PLX8394,PLX-8394;plixorafenib;(R)-N-[3-[5-(2-Cyclopropyl-5-pyrimidinyl)-7-azaindole-3-carbonyl]-2,4-difluorophenyl]-3-fluoropyrrolidine-1-sulfonamide | | CAS: | 1393466-87-9 | | MF: | C25H21F3N6O3S | | MW: | 542.53 | | EINECS: | | | Product Categories: | | | Mol File: | 1393466-87-9.mol |  |
| | PLX8394 Chemical Properties |
| density | 1.60±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : ≥ 39 mg/mL (71.89 mM);Water : < 0.1 mg/mL (insoluble) | | pka | 6.33±0.40(Predicted) |
| | PLX8394 Usage And Synthesis |
| Uses | Combination therapies comprising KRAS G12C inhibitors and Raf kinase inhibitors for treating KRAS G12C cancers.BRAF inhibitor. |
| | PLX8394 Preparation Products And Raw materials |
|